Telix Pharmaceuticals Limited announced that its Telix Manufacturing Solutions (TMS) facility in Brussels South (Seneffe), Belgium, has produced its first Good Manufacturing Practice (GMP)-grade commercial radiopharmaceutical doses and delivered them to the AIRC hospital collaboration in Charleroi, Belgium. TMS Brussels South is one of Europe’s largest radiopharmaceutical production facilities, with nine GMP lines, clean rooms, a radiopharmacy, and two cyclotrons across a 2,800 square metre footprint. Telix Brussels South can now manufacture GMP-grade ‘hot doses’ that are ready for patients today.
And beyond this, the impressive research, development and manufacturing scale-up capabilities mean that it will also serve as a vital hub for future production of clinically and commercially important isotopes and radiopharmaceuticals.